Constitutive activation of SHP2 protein tyrosine phosphatase inhibits ICSBP-induced transcription of the gene encoding gp91PHOX during myeloid differentiation

Journal of Leukocyte Biology

Volumn 83, Issue 3, 2008, Pages 680-691

  Zhu, Chunliu ^a   Lindsey, Stephan ^a   Konieczna, Iwonna ^a   Eklund, Elizabeth A ^a,b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b JESSE BROWN VA MEDICAL CENTER   (United States)

Author keywords

Gene regulation; IFN consensus sequence binding protein; Respiratory burst oxidase

Indexed keywords

INTERFERON CONSENSUS SEQUENCE BINDING PROTEIN; PROTEIN TYROSINE PHOSPHATASE SHP 2; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; CYBB PROTEIN, HUMAN; INTERFERON REGULATORY FACTOR; MEMBRANE PROTEIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE;

ANIMAL CELL; BONE MARROW CELL; CELL DIFFERENTIATION; CELL STRAIN U937; CONFERENCE PAPER; CONTROLLED STUDY; HUMAN; HUMAN CELL; MOUSE; MYELODYSPLASTIC SYNDROME; MYELOID PROGENITOR CELL; MYELOPOIESIS; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; RESPIRATORY BURST; TRANSCRIPTION INITIATION; ANIMAL; ARTICLE; CELL CULTURE; CYTOLOGY; DRUG EFFECT; ENZYME ACTIVATION; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; GENETICS; METABOLISM; PHAGOCYTE; PHYSIOLOGY; PROTEIN SYNTHESIS; REPORTER GENE;

ANIMALS; BONE MARROW CELLS; CELL DIFFERENTIATION; CELLS, CULTURED; ENZYME ACTIVATION; GENES, REPORTER; HUMANS; INTERFERON REGULATORY FACTORS; MEMBRANE GLYCOPROTEINS; MICE; NADPH OXIDASE; PHAGOCYTES; PROTEIN BIOSYNTHESIS; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 11; TRANSCRIPTION, GENETIC; TRANSFECTION; U937 CELLS;

EID: 43349083585     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0807514     Document Type: Conference Paper

References (43)

1. Nelson, N., Marks, M. S., Driggers, P. H., Ozato, K. (1993) Interferon consensus sequence-binding protein, a member of the interferon regulatory factor family, suppresses interferon-induced gene transcription. Mol. Cell. Biol. 13, 588-599.
2. Eklund, E. A., Jalava, A., Kakar, R. (1998) PU.1, interferon regulatory factor 1, and interferon consensus sequence-binding protein cooperate to increase gp91(phox) expression. J. Biol. Chem. 273, 13957-13965.
3. Kautz, B., Kakar, R., David, E., Eklund, E. A. (2001) SHP1 protein-tyrosine phosphatase inhibits gp91PHOX and p67PHOX expression by inhibiting interaction of PU.1, IRF1, interferon consensus sequence-binding protein, and CREB-binding protein with homologous Cis elements in the CYBB and NCF2 genes. J. Biol. Chem. 276, 37868-37878.
4. Rehli, M., Poltorak, A., Schwarzfischer, L., Krause, S. W., Andreesen, R., Beutler, B. (2000) PU.1 and interferon consensus sequence-binding protein regulate the myeloid expression of the human Toll-like receptor 4 gene. J. Biol. Chem. 275, 9773-9781.
5. Wang, I. M., Contursi, C., Masumi, A., Ma, X., Trinchieri, G., Ozato, K. (2000) An IFN-γ-inducible transcription factor, IFN consensus sequence binding protein (ICSBP), stimulates IL-12 p40 expression in macrophages. J. Immunol. 165, 271-279.
6. Holtschke, T., Löhler, J., Kanno, Y., Fehr, T., Giese, N., Rosenbauer, F., Lou, J., Knobeloch, K. P., Gabriele, L., Waring, J. F., Bachmann, M. F., Zinkernagel, R. M., Morse III, H. C., Ozato, K., Horak, I. (1996) Immunodeficiency and chronic myelogenous leukemia-like syndrome in mice with a targeted mutation of the ICSBP gene. Cell 87, 307-317.
7. Scheller, M., Foerster, J., Heyworth, C. M., Waring, J. F., Lohler, J., Gilmore, G. L., Shadduck, R. K., Dexter, T. M., Horak, I. (1999) Altered development and cytokine responses of myeloid progenitors in the absence of transcription factor, interferon consensus sequence binding protein. Blood 94, 3764-3771.
8. Zhu, C., Saberwal, G., Ly, Y. F., Platanias, L. C., Eklund, E. A. (2004) The interferon consensus sequence-binding protein activates transcription of the gene encoding Neurofibromin 1. J. Biol. Chem. 279, 50874-50885.
9. Huang, W., Saberwal, G., Horvath, E., Zhu, C., Lindsey, S., Eklund, E. A. (2006) Leukemia-associated, constitutively active mutants of SHP2 protein tyrosine phosphatase inhibit NF1 transcriptional activation by the interferon consensus sequence binding protein. Mol. Cell. Biol. 26, 6311-6332.
10. Huang, W., Horvath, E., Eklund, E. A. (2007) PU.1, interferon regulatory factor 2, and the interferon consensus sequence binding protein cooperate to activate NF1 transcription in differentiating myeloid cells. J. Biol. Chem. 282, 6629-6643.
11. Qian, Z., Fernald, A. A., Godley, L. A., Larson, R. A., Le Beau, M. M. (2002) Expression profiling of CD34+ hematopoietic stem/progenitor cells reveals distinct subtypes of therapy related acute myeloid leukemia. Proc. Natl. Acad. Sci. USA 99, 14925-14930.
12. Schmidt, M., Nagel, S., Proba, J., Theide, C., Ritter, M., Waring, J. F., Rosenbauer, F., Huhn, D., Wittig, B., Horak, I., Neubauer, A. (1998) Lack of interferon consensus sequence binding protein (ICSBP) transcripts in human myeloid leukemias. Blood 91, 22-29.
13. Tamura, T., Thotakura, P., Tanaka, T. S., Ko, M. S. H., Ozato, K. (2005) Identification of target genes and a unique cis element regulated by IRF8 in developing macrophages. Blood 106, 1938-1947.
14. Royer-Pokora, B., Kunkle, L. M., Monaco, A. P., Goff, S. C., Newburger, P. E., Baehner, R. L., Cole, F. S., Curnutte, J. T., Orkin, S. H. (1986) Cloning the gene for an inherited human disorder, chronic granulomatous disease, on the basis of its chromosomal location. Nature 322, 32-38.
15. Leto, T. L., Lomax, K. J., Volpp, B. D., Nunio, H., Sechler, J. M. G., Nauseef, W. M., Clark, R., Gallin, J. I., Malech, H. L. (1990) Cloning of a 67-kD neutrophil oxidase factor with similarity to a non-catalytic region of p60 c-src. Science 248, 727-730.
16. Newburger, P. E., Dai, Q., Whitney, C. (1991) In vitro regulation of human phagocyte cytochrome b heavy and light chain gene expression by bacterial lipopolysaccharide and recombinant human cytokines. J. Biol. Chem. 266, 16171-16177.
17. Levy, R., Rostrosen, D., Nagauker, O., Leto, T. L., Malech, H. L. (1990) Induction of the respiratory burst in HL60 cells. Correlation of function and protein expression. J. Immunol. 145, 2595-2601.
18. Sharf, R., Meraro, D., Azreil, A., Thornton, A. M., Ozato, K., Petricoin, E. F., Larner, A. C., Schaper, R., Hauser, H., Levi, B-Z. (1997) Phosphorylation events modulate the ability of ICSBP to interact with IRFs and to bind DNA. J. Biol. Chem. 272, 9785-9792.
19. Fragale, A., Tartaglia, M., Wu, J., Gelb, B. D. (2004) Noonan syndrome-associated SHP2/PTPN11 mutants cause EGF-dependent prolonged GAB1 binding and sustained ERK2/MAPK1 activation. Hum. Mutat. 23, 267-277.
20. Bentires-Alj, M., Paez, J. G., David, F. S., Keilhack, H., Halmos, B., Naoki, K., Maris, J. M., Richardson, A., Bardelli, A., Sugarbaker, D. J., Richards, W. G., Du, J., Girard, L., Minna, J. D., Loh, M. L., Fisher, D. E., Velculescu, V. E., Vogelstein, B., Meyerson, M., Sellers, W. R., Neel, B. G. (2004) Activating mutations of the Noonan syndrome-associated SHP2/PTPN11 gene in human solid tumors and adult acute myelogenous leukemia. Cancer Res. 64, 8816-8820.
21. Tartaglia, M., Neimeyer, C. M., Fragale, A., Song, X., Buechner, J., Jung, A., Hahlen, K., Hasle, H., Licht, J. D., Gelb, B. D. (2003) Somatic mutations in PTPN11 in juvenile myelomonocytic leukemia, myelodysplastic syndromes and acute myeloid leukemia. Nat. Genet. 34, 148-150.
22. Keilhack, H., David, F. S., McGregor, M., Cantley, L. C., Neel, B. G. (2005) Diverse biochemical properties of Shp2 mutants. Implications for disease phenotypes. J. Biol. Chem. 280, 30984-30993.
23. Zabernigg, A., Hilbe W., Eisterer, W., Greil, R., Ludescher, C., Thaler, J. (1997) Cytokine priming of the granulocyte respiratory burst in myelodysplastic syndromes. Leuk. Lymphoma 27, 137-143.
24. Larrick, J. W., Anderson, S. J., Koren, H. S. (1980) Characterization of a human macrophage-like cell line stimulated in vitro: a model of macrophage functions. J. Immunol. 125, 6-14.
25. Dignam, J. D., Lebovitz, R. M., Roeder, R. G. (1983) Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11, 1475-1479.
26. Weinmann, A. S., Bartley, S. M., Zhang, T., Zhang, M. Q., Farnham, P. J. (2001) Use of chromatin immuno-precipitation to clone novel E2F target promoters. Mol. Cell. Biol. 21, 6820-6832.
27. Ezekowitz, R. A., Orkin, S. H., Newburger, P. E. (1987) Recombinant interferon γ augments phagocyte superoxide production and X-linked chronic granulomatous disease gene expression in X-linked variant chronic granulomatous disease. J. Clin. Invest. 80, 1009-1016.
28. Harder, K. W., Owen, P., Wong, L. K., Aebersold, R., Clark-Lewis, I., Jirik, F. R. (1994) Characterization and kinetic analysis of the intracellular domain of human protein tyrosine phosphatase β (HPTP β) using synthetic phosphopeptides. Biochem. J. 298, 395-401.
29. Lindsey, S., Huang, W., Wang, H., Horvath, E., Zhu, C., Eklund, E. A. (2007) Activation of SHP2 protein-tyrosine phosphatase increases HoxA10-induced repression of the genes encoding gp91(PHOX) and p67(PHOX). J. Biol. Chem. 282, 2237-2249.
30. Shultz, L. D., Bailey, Cl., Coman, D. R. (1983) Hematopoietic stem cell function in motheaten mice. Exp. Hematol. 11, 667-680.
31. Shultz, L. D., Coman, D. R., Bailey, C. L., Beamer, W. G., Sidman, C. L. (1984) "Viable motheaten" a new allele at the motheaten locus. Am. J. Pathol. 116, 179-192.
32. Van Zant, G., Shultz, L. (1989) Hematologic abnormalities of the immunodeficient mouse mutant, viable motheaten (mev). Exp. Hematol. 17, 81-87.
33. Schubbert, S., Lieuw, K., Rowe, S. L., Lee, C. M., Li, X., Loh, M. L., Clap, D. W., Shannon, K. M. (2005) Functional analysis of leukemia-associated PTPN11 mutations in primary hematopoietic cells. Blood 106, 311-317.
34. Eklund, E. A., Goldenberg, I., Lu, Y., Andrejic, J., Kakar, R. (2000) SHP1 protein tyrosine phosphatase regulates HoxA10 DNA-binding and transcriptional repression activity in undifferentiated myeloid cells. J. Biol. Chem 39, 36878-36888.
35. Eklund, E. A., Jalava, A., Kakar, R. (2000) Tyrosine phosphorylation decreases HoxA10 DNA-binding and transcriptional repression during IFNγ induced differentiation in myeloid cell lines. J. Biol. Chem. 275, 20117-20126.
36. Christiansen, D. H., Desta, F., Andersen, M. K., Pedersen-Bjergaard, J. (2007) Mutations of the PTPN11 gene in therapy related MDS and AML with rare balanced chromosome translocations. Genes Chromosomes Cancer 46, 517-521.
37. Ohsaka, A., Kitagawa, S., You, A., Motoyoshi, K., Furusawa, S., Miura, Y., Takaku, F., Saito, M. (1993) Effects of granulocyte colony stimulating factor and granulocyte macrophage colony stimulating factor on respiratory burst activity of neutrophils in patients with myelodysplastic syndromes. Clin. Exp. Immunol. 91, 308-313.
38. Jadersten, M., Montgomery, S. M., Dybedal, I., Porwit-MacDonald, A., Hellstrom-Lindberg, E. (2005) Long-term outcome of treatment of anemia in MDS with erythropoietin and G-CSF. Blood 106, 803-811.
39. Sattler, M., Mohi, M. G., Pride, Y. B., Quinnan, L. R., Malouf, N. A., Podar, K., Gesbert, F., Iwasaki, H., Li, S., Van Etten, R. A., Gu, H., Griffin, J. D., Neel, B. G. (2002) Critical role for Gab2 in transformation by Bcr/abl. Cancer Cell 1, 479-492.
40. Scherr, M., Chaturvedi, A., Battmer, K., Dallmann, I., Schultheis, B., Ganser, A., Eder, M. (2006) Enhanced sensitivity to inhibition of SHP2, Stat5 and Gab2 expression in chronic myeloid leukemia. Blood 107, 3279-3287.
41. Kaplan, S. S., Berkow, R. L., Joyce, R. A., Basford, R. E., Barton, J. C. (1992) Neutrophil function in chronic neutrophilic leukemia: defective respiratory burst in response to phorbol esters. Acta Haematol. 87, 16-21.
42. Schmidt, M., Hochhaus, A., Nitsche, A., Hehlmann, R., Neubauer, A. (2001) Expression of nuclear transcription factor interferon consensus sequence binding protein in chronic myeloid leukemia correlates with pretreatment risk features and cytogenetic response to interferon-α. Blood 97, 3648-3650.
43. Aswald, J. M., Lipton, J. H., Messmer, H. A. (2002) Intracellular cytokine analysis of interferon-γ in T cells of patients with chronic myeloid leukemia. Cytokines Cell. Mol. Ther. 7, 75-82.